Navigation Links
R-Tech Ueno Starts Early Phase II Clinical Trial for RK-023
Date:10/6/2009

s release related July 16, 2009 for more information about the Phase I clinical trial.
  • In a double-blind test, for the purpose of conducting the clinical trial in a completely objective manner, the physicians performing the trial as well as the patients participating in the trial do not know if the substance administered to each individual is the drug being tested or the placebo.
  • The placebo is a substance that does not include the drug being tested (RK-023 in this case).
  • About R-Tech Ueno, Ltd.

    R-Tech Ueno was established in September 1989 for the purpose of marketing and R&D of drugs. Under the leadership of the CEO, also a medical doctor, the company is developing new drugs on the theme "Physician-Oriented New Drug Innovation," targeting ophthalmologic and dermatologic diseases that previously had no effective therapeutic agent. The company's main product Rescula(R) eyedrop 0.12% is a therapeutic drug for glaucoma and ocular hypertension and has been marketed in Japan since 1994. R-Tech Ueno was the first in the world to take advantage of the substance "prostone" in the development of Rescula(R). Prostone was discovered in 1980 by Dr. Ryuji Ueno, the founder of the company. Rescula(R) eyedrop 0.12% that causes less topical and systemic adverse reactions demonstrates steady ocular pressure-decreasing action by twice-a-day instillation. Such excellent therapeutic effects are realized through its optic nerve protection and ocular blood flow-increasing mechanism.

        Stock Code: No.4573, Osaka Securities Exchange; Hercules
        Head Office: 1-1-7 Uchisaiwai-cho, Chiyoda-ku, Tokyo
        Representative Director & President: Yukihiko Mashima
    
    
        Contact:
        Koji Nakamura,
        Business Management Department
        R-Tech Ueno, Ltd.
        Tel: +81-3-3596-8011
        e-mail: koji.nakamura@rtueno.co.jp
        URL: '/>"/>
    SOURCE R-Tech Ueno, Ltd.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
    2. R-Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0.15% UF-021
    3. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
    4. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
    5. Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
    6. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
    7. U.S. NCI Starts Enrolment in Phase 2 Systemic Melanoma Clinical Trial with REOLYSIN(R)
    8. Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
    9. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
    10. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
    11. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/2/2015)... July 2, 2015  New product launches are critical ... role in educating thought leaders about new products, Medical ... influence how well a new therapy performs at launch. ... research and consulting leader Best Practices, LLC, critical aspects ... focus on are early stage thought leader (TL) interaction, ...
    (Date:7/2/2015)... According to a new market research report " ... Transcranial Magnetic Stimulation), Application (Depression, Parkinson,s, Tinnitus, Alzheimer,s, Epilepsy, Ischemia, ... the global Neuromodulation Market is estimated at $3.65 Billion in ... at a CAGR of 11.2% during the forecast period. ... market data T ables and 32 ...
    (Date:7/2/2015)... Conn. , July 2, 2015 Numotion,s ... Executive Officer announced that Tamas Feitel has ... Feitel joins Numotion after a highly successful 18 year ... leadership roles driving strategy, profitability, and productivity to result ... most recent position was Chief Financial Officer for GE ...
    Breaking Medicine Technology:Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Neuromodulation Market Worth $6.20 Billion by 2020 2Neuromodulation Market Worth $6.20 Billion by 2020 3Neuromodulation Market Worth $6.20 Billion by 2020 4Numotion Names Tamas Feitel Chief Financial Officer 2
    ... , WILMINGTON, Del. ... System is taking a giant leap forward toward a ... Order Entry (CPOE), technology that makes it easier, more efficient ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090407/DC95299LOGO ) , The system goes live on ...
    ... , HOFFMAN ESTATES, Ill. , Jan. 28 ... Drug Administration (FDA) has given 510(k) marketing clearance to both ... , The DYNA-LINK system features a next-generation stand-alone device that ... is a thoracolumbar plating system that features multiple types of ...
    Cached Medicine Technology:Christiana Care Health System Rolls Out Electronic Computerized Provider Order Entry 2
    (Date:7/2/2015)... ... July 02, 2015 , ... Six months ahead of ... cross-country walk to raise awareness and money for the Pulmonary Hypertension Association (PHA). ... at PHA’s headquarters near Washington, D.C. by mid-September. He left Glasgow, Mont. yesterday morning ...
    (Date:7/2/2015)... (PRWEB) , ... July 02, ... ... wound therapy (NPWT) - pipeline review 2015” provides comprehensive information on the ... development. Complete report on negative pressure wound therapy (NPWT) with 22 market ...
    (Date:7/2/2015)... ... ... Time Pain Relief (RTPR), makers of the popular rub-on pain relief lotion and products, ... The Fifth Annual Big Sky Professional Bull Riders Event being held this month at Big ... relief lotion and products at the family friendly event that features two days of bull ...
    (Date:7/2/2015)... ... July 02, 2015 , ... Five individuals from ... in Anniston for specialized disaster training. The team – composed of four clinicians ... California Hospital Association who attended the training, which is dedicated to preparing first ...
    (Date:7/2/2015)... ... July 02, 2015 , ... B. ... has been retained to lead a national chief operating officer recruitment ... firms in the healthcare industry, B. E. Smith has recently placed more than ...
    Breaking Medicine News(10 mins):Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Negative Pressure Wound Therapy (System, Wound Care, Tissue Cooling NPWT) Pipeline Review 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 2Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 3Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 2Health News:Team from Loma Linda University Health Receives Specialized Disaster Training at FEMA’s Center for Domestic Preparedness 3Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 2Health News:Nicklaus Children’s Hospital Retains B. E. Smith to Recruit New Chief Operating Officer 3
    ... Va. -- Virginia Commonwealth University School of Medicine researchers ... into an expectant mother,s blood vessels may explain high ... to novel avenues of treatment for pregnant women with ... neutrophilis, their products or their cellular effects. ...
    ... MONDAY, Oct. 31 (HealthDay News) --,The longer they live in ... immigrants will develop health problems, a new study says. ... Nutrition Examination Survey and discovered a dramatic increase in obesity, ... in the United States for more than 20 years. ...
    ... and its biological bases, drives the economy at Neuroscience ... What role does human decision-making play in driving modern ... the biological mechanisms of reward anticipation, risk-taking, and emotion ... economist Robert Shiller, PhD, economist and author of "Animal ...
    ... themselves are more liberal in their advice to patients ... is harmful, and while men who are heavy drinkers ... stop altogether, reveals a thesis from the Sahlgrenska Academy ... the University of Gothenburg,s Sahlgrenska Academy have for the ...
    ... WASHINGTON, Oct. 31Like normal tissue, tumors thrive on nutrients ... growth of new blood vessels is a hallmark of ... growth can keep tumors from growing, too. To better ... researchers would like to make detailed maps of the ...
    ... in blood samples to the study of protein synthesis, Quartz ... In this technique, antibodies anchored to gold electrodes on a ... sticky side of a Velcro strap, grabbing molecules of interest ... surface of the sensor, the more sensitive the QCM device,s ...
    Cached Medicine News:Health News:Virginia Commonwealth University findings may help explain high blood pressure in pregnancy 2Health News:Life in U.S. Not Always a Plus for Immigrants' Health 2Health News:Doctors' own alcohol consumption colors advice to patients 2
    ... stability to help relieve low back discomfort. ... for a cool, comfortable, custom fit. Optional ... support to the spine. Wide elastic adjustment ... low back - easily accessed and adjusted. ...
    ... comes to superior immobilization and cervical spine care, ... ,You already know that the most important function ... c-spine. But what you may not know is ... ®: provides superior immobilization over the leading one-piece ...
    ... Saver" hip abduction orthosis provides the same comfortable ... one major difference. Our design innovation enables the ... for use in either left or right handed ... rights. A comfortable neoprene padding is secured to ...
    ... classic orthosis provides firm support and stabilization ... primary or revision total hip arthroplasty. Neoprene ... acts as a wicking interface. This brace ... patented Infinity or Genesis joints. , ...
    Medicine Products: